stockrowTarsus Pharmaceuticals, Inc. (TARS) vs Tango Therapeutics, Inc. (TNGX)
- Tarsus Pharmaceuticals, Inc. TARS 68.81 +1.91%
- Tango Therapeutics, Inc. TNGX 21.50 +3.02%
Tarsus Pharmaceuticals, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. and Tango Therapeutics, Inc. are of similar size ($3.5B and $3.3B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.3% against 48.3%. Tango Therapeutics, Inc. has the higher net margin (0.00% vs −102.9%) and the lower return on invested capital (−808.4% vs 0.00%). Across the 17 metrics below, Tango Therapeutics, Inc. leads on 10 and Tarsus Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | TARS | TNGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.21% | 100.00% | 68.51% |
| Operating margin | (102.04%) | 0.00% | 0.00% |
| Net margin | (102.93%) | 0.00% | 0.00% |
| Free cash flow margin | 4.76% | 0.00% | 0.00% |
| Return on equity | (319.84%) | (21.34%) | (51.96%) |
| Return on assets | (135.04%) | (18.86%) | (46.06%) |
| Return on invested capital | 0.00% | (808.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack